Skip to content
Recall Observatory FDA recall evidence

Drug product

ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35

D-181-2013

November 02, 2012

Class II

Product summary

Firm
Bristol Myers Squibb Manufacturing Company
Event
Event 63706
Status
Terminated
Classification
Class II
Quantity
21 blister packs
Official record key
drug-enforcement:D-181-2013

Official wording

Reason: CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.

Code information: 2E69023A, Exp. FEB 28 2015

Distribution pattern: LA, TN, CA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations